April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Retinal Ganglion Cell Loss Evaluation by Flow Cytometry After Intravitreal Injection of Endothelin-1 in the Rat
Author Affiliations & Notes
  • B. Bardet
    INRA, University of Burgundy, Eye & Nutrition Research Group, Dijon, France
  • A. Sequeira-Le Grand
    Flow Cytometry Department, University of Burgundy, Dijon Cedex, France
  • N. Acar
    INRA, University of Burgundy, Eye & Nutrition Research Group, Dijon, France
  • C. P. Garcher
    INRA, University of Burgundy, Eye & Nutrition Research Group, Dijon, France
    Ophthalmology, University Hospital, Dijon, France
  • A. M. Bron
    INRA, University of Burgundy, Eye & Nutrition Research Group, Dijon, France
    Ophthalmology, University Hospital, Dijon, France
  • L. Bretillon
    INRA, University of Burgundy, Eye & Nutrition Research Group, Dijon, France
  • Footnotes
    Commercial Relationships  B. Bardet, None; A. Sequeira-Le Grand, None; N. Acar, None; C.P. Garcher, None; A.M. Bron, None; L. Bretillon, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 6127. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. Bardet, A. Sequeira-Le Grand, N. Acar, C. P. Garcher, A. M. Bron, L. Bretillon; Retinal Ganglion Cell Loss Evaluation by Flow Cytometry After Intravitreal Injection of Endothelin-1 in the Rat. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6127.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinal Ganglion Cell (RGC) quantification is a critical point to assess the relevance of an animal model of glaucoma or the efficacy of drugs that target RGC degeneration. The aim of the present study was to evaluate the feasibility and the reliability of flow cytometry as a new tool for counting RGCs.

Methods: : RGC loss was induced in Wistar rats (n=10) by intravitreal injection of 5µL of 500µM endothelin-1. The controlateral eye was used as a control. A control group (n=9) received a 5µL-intravitreal injection of saline. After one week, retinas were harvested and manually homogenized in order to obtain a single-cell suspension. Primary anti-Thy1.1 (CD90) antibody was used as a marker for RGCs. A secondary fluorescent antibody was subsequently incubated. Negative control incubations were performed with non relevant IgG as primary antibody. Thereafter, cells were rinsed and resuspended in PBS before analysis by flow cytometry. Another group of rats (n=10) was investigated by Fluorogold retrolabelling after intravitreal injection of endothelin-1. The Fluorogold staining was evaluated by flow cytometry.

Results: : RGCs loss after 5µL intravitreal injection of 500µM endothelin-1 was 24.2 ± 6.7% compared with controlateral eye. No RGC loss was observed in the sham operated group. The coefficient of variation for this technique was from 1.1% to 3.1% in controls. The specificity of this method for counting RGC was confirmed by assessing that Thy1.1 positive cells were also labelled with Fluorogold.

Conclusions: : Based on our preliminary findings, we suggest that flow cytometry is a convenient, rapid and reliable technique for relative quantification of RGC loss in rat models of glaucoma.

Keywords: ganglion cells • flow cytometry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×